| Bioactivity | Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity. Protein kinase C (PKC) TFA is involved in controlling the function of other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acid residues on these proteins[1][2]. |
| Name | Protein Kinase C (19-31) (TFA) |
| Sequence | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val |
| Shortening | RFARKGALRQKNV |
| Formula | C69H119F3N26O18 |
| Molar Mass | 1657.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Protein Kinase C (19-31) (TFA)
CAS: F: C69H119F3N26O18 W: 1657.84
Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulator
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.